Sublime
An inspiration engine for ideas
For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
Dallas-based Colossal Biosciences, the self-described de-extinction company behind the woolly mammoth and thylacine, today announced that it is spinning off Form Bio, as an independent software company offering a computational life sciences platform that bridges the gap between data and discovery.
Colossal Biosciences spins off Form Bio software, offers platform for advanced, AI-based applications
The Fund: Ray Dalio, Bridgewater Associates, and the Unraveling of a Wall Street Legend
amazon.com
Mercer_Pub 248
The study describes the development of a continuous evolution system to engineer small degron tags that can be inserted into endogenous genes and selectively degrade proteins using specific small molecules.
LinkLeo Melamed, Man of the Futures: The Story of Leo Melamed & the Birth of Modern Finance
J. Christopher Giancarlo, Cameron Winklevoss, • CryptoDad: The Fight for the Future of Money
When the pandemic hit, Cowen and Collison, the founder of Stripe, set up a separate grant programme to fund research. The pair had raised and spent millions before larger bodies managed to respond. One large grant went to Anne Wylie, who developed saliva tests for covid-19. Though Wylie was a researcher at the Yale School of Public Health, and atta... See more